A detailed history of Azimuth Capital Investment Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Azimuth Capital Investment Management LLC holds 101,371 shares of ABBV stock, worth $18.2 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
101,371
Previous 100,062 1.31%
Holding current value
$18.2 Million
Previous $17.2 Million 16.64%
% of portfolio
0.81%
Previous 0.71%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $214,466 - $260,922
1,309 Added 1.31%
101,371 $20 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $2.13 Million - $2.49 Million
13,750 Added 15.93%
100,062 $17.2 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $56,576 - $64,463
-354 Reduced 0.41%
86,312 $15.7 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $317,856 - $357,980
-2,310 Reduced 2.6%
86,666 $13.4 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $78,417 - $90,779
587 Added 0.66%
88,976 $13.3 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $1.38 Million - $1.72 Million
-10,446 Reduced 10.57%
88,389 $11.9 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $297,607 - $342,739
-2,058 Reduced 2.04%
98,835 $15.8 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $325,581 - $390,457
-2,354 Reduced 2.28%
100,893 $16.3 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $600,455 - $688,682
-4,474 Reduced 4.15%
103,247 $13.9 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $14.8 Million - $18.8 Million
107,721 New
107,721 $16.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Azimuth Capital Investment Management LLC Portfolio

Follow Azimuth Capital Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azimuth Capital Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Azimuth Capital Investment Management LLC with notifications on news.